Scientists have made rapid progress in customizing drugs for ultrarare diseases. The hard part now is making such treatments on a large scale.
from NYT > Health https://ift.tt/wtXpNDr
December 19, 2022
Rose
Health - The New York Times, NYT > Health
No comments
Related Posts:
Why Measles Outbreaks May Be the New NormalRecent Trump administration actions are setting the stage for a measles resurgence, experts fear. from NYT > Health https://ift.tt/N5yhgO7 … Read More
How Measles Attacks an Unvaccinated ChildWith falling vaccination rates and outbreaks that have caused more than 580 U.S. cases and at least one death, health experts expect hundreds or even thousands more to be infected in the coming months. from NYT > Health h… Read More
Overlooked No More: Katharine McCormick, Force Behind the Birth Control PillShe used her wealth strategically to expand opportunities for women, underwriting the development of the pill and supporting the suffrage movement. from NYT > Health https://ift.tt/ZBtisW6 … Read More
Supreme Court Rules Against Makers of Flavored Vapes Popular With TeensThe justices handed a win, for now, to the Food and Drug Administration in its rejection of applications from makers of flavored liquids used in e-cigarettes. from NYT > Health https://ift.tt/w87Rh3o … Read More
Trump’s Next Tariffs Target Could be Foreign-Made PharmaceuticalsPresident Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs. from NYT > Health https://ift.tt/GK1M0jO … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment